Plain-English translation of NCT07427160 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying a procedure called pneumatic displacement, which uses a gas bubble to help move blood away from the center of the retina in people with age-related macular degeneration. The researchers want to understand whether the type of abnormal blood vessel growth that caused the bleeding affects how well the treatment works and how much vision patients recover afterward.
Bleeding in the center of the eye can cause serious vision loss in older adults with macular degeneration. Different types of abnormal blood vessel growth cause this bleeding, and doctors want to know if each type responds differently to treatment so they can better predict which patients will recover their vision.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would receive the pneumatic displacement procedure (a gas bubble injection into your eye) to help move the bleeding away from the center of your vision. You would then return for follow-up visits over at least 6 months so doctors can check how your eye heals, measure your vision, and take images to compare your recovery with other patients who had different types of blood vessel growth.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Italy
Sponsor
Marco Mazzola
Enrollment target
~60 participants
Started
October 2025
Primary completion
October 2026
Age range
50 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
marco mazzola, medical doctor
Azienda Sanitaria Universitaria Integrata del Trentino
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.